Xeris Pharmaceuticals, Inc. SBIR Phase I Award,
A SBIR Phase I contract was awarded to Xeris Pharmaceuticals, Inc. for $157,478.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
157,478
SBIR/STTR Award Recipient
Contract Number (US Government)
1R43DK085809-01
Award Phase
Phase I
Award Type
SBIR
Official Website
Find more entities like Xeris Pharmaceuticals, Inc. SBIR Phase I Award,
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
